Table 2 Procedural and Clinical Outcomes

 Device success

98 (98)

23 (95.8)

19 (95)

0.683

 Bleeding

5 (5)

1 (4.2)

0 (0)

0.593

  Life-threatening bleeding

0 (0)

0 (0)

0 (0)

…

  Major bleeding

3 (3)

0 (0)

0 (0)

0.510

  Minor bleeding

2 (2)

1 (4.2)

0 (0)

0.625

 Vascular complication

6 (6)

1 (4.2)

1 (5)

0.933

  Major

3 (3)

1 (4.2)

1 (5)

0.887

  Minor

3 (3)

0 (0)

0 (0)

0.510

 Cerebrovascular accident

2 (2)

0 (0)

1 (5)

0.510

 Coronary artery obstruction

0 (0)

0 (0)

0 (0)

…

 Pacemaker insertion^a

8/89 (8.9)

4 (16.7)

5 (25)

0.125

 Paravalvular leak (<moderate)

100 (100)

24 (100)

20 (100)

1.000

 Acute kidney injury^b

5/98 (5.1)

3/23 (13.0)

4/17 (23.5)

0.032

  Stage 1

3 (3)

2 (8.3)

3 (15)

0.048

  Stage 2

2 (2)

1 (4.2)

1 (5)

0.617

 30-day Mortality

2 (2)

0 (0)

1 (5)

0.510

 Transfusion

5 (5)

0 (0)

2 (10)

0.305

 New-onset atrial fibrillation^c

3/65 (4.6)

1/18 (5.6)

5/15 (33.3)

0.002

 Postoperative NYHA III/IV

9 (9)

2 (8.3)

2 (10)

0.982

 Mean gradient, mmHg

10.2 ± 4.4

8.7 ± 3.2

9.2 ± 3.6

0.187

 Discharge to rehabilitation

14 (14)

4 (16.7)

7 (35)

0.077

 30-day readmission

8 (8)

2 (8.3)

7 (35)

0.002